186 related articles for article (PubMed ID: 33129835)
21. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
22. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications.
Fukuta T; Kogure K
Chem Pharm Bull (Tokyo); 2022; 70(5):334-340. PubMed ID: 35491189
[TBL] [Abstract][Full Text] [Related]
23. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664
[TBL] [Abstract][Full Text] [Related]
24. Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.
Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud AM; Sgouros G
J Liposome Res; 2005; 15(1-2):15-27. PubMed ID: 16194925
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016
[TBL] [Abstract][Full Text] [Related]
26. Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.
Perillo E; Porto S; Falanga A; Zappavigna S; Stiuso P; Tirino V; Desiderio V; Papaccio G; Galdiero M; Giordano A; Galdiero S; Caraglia M
Oncotarget; 2016 Jan; 7(4):4077-92. PubMed ID: 26554306
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A
Tagami T; Ando Y; Ozeki T
Int J Pharm; 2017 Jan; 517(1-2):35-41. PubMed ID: 27865984
[TBL] [Abstract][Full Text] [Related]
28. Development of Functional Chimeric Nanoparticles by Membrane Fusion of Small Extracellular Vesicles and Drug-Encapsulated Liposomes.
Fukuta T; Nishikawa A; Hiramachi A; Yamashita S; Kogure K
Biol Pharm Bull; 2023; 46(8):1098-1104. PubMed ID: 37532560
[TBL] [Abstract][Full Text] [Related]
29. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
[TBL] [Abstract][Full Text] [Related]
30. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
31. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
32. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
33. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
[TBL] [Abstract][Full Text] [Related]
34. Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicity.
Nishida K; Kashiwagi M; Shiba S; Muroki K; Ohishi A; Doi Y; Ando H; Ishida T; Nagasawa K
Toxicol Appl Pharmacol; 2017 Dec; 337():76-84. PubMed ID: 29054682
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
36. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration.
Tagami T; Kubota M; Ozeki T
J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287
[TBL] [Abstract][Full Text] [Related]
37. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
38. Choline phosphate lipid as an intra-crosslinker in liposomes for drug and antibody delivery under guard.
Li S; Xie X; Wang W; Jiang S; Mei W; Zhang Y; Liu S; Yu X
Nanoscale; 2022 Feb; 14(6):2277-2286. PubMed ID: 35080548
[TBL] [Abstract][Full Text] [Related]
39. Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk-Shell Structure Augment Cancer Chemotherapy.
Nie D; Dai Z; Li J; Yang Y; Xi Z; Wang J; Zhang W; Qian K; Guo S; Zhu C; Wang R; Li Y; Yu M; Zhang X; Shi X; Gan Y
Nano Lett; 2020 Feb; 20(2):936-946. PubMed ID: 31671946
[TBL] [Abstract][Full Text] [Related]
40. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
